Does Vraylar Help with Flashbacks?
No, there is no evidence that Vraylar (cariprazine) helps with flashbacks, and it is not mentioned in any clinical guidelines for treating PTSD-associated nightmares or flashbacks. Your patient was likely on Abilify (aripiprazole) for nightmares or other PTSD symptoms, not specifically flashbacks, as aripiprazole has some evidence for treating PTSD-associated nightmares.
Understanding the Evidence Gap
The American Academy of Sleep Medicine's 2018 position paper on nightmare disorder provides comprehensive pharmacologic recommendations for PTSD-associated symptoms 1. Aripiprazole is specifically listed as a medication that "may be used" for PTSD-associated nightmares 1. The evidence for aripiprazole comes from a case series of 5 veterans with combat-related PTSD who showed substantial improvement in nightmare frequency and intensity at doses of 15-30 mg/day 1.
Cariprazine (Vraylar) is completely absent from these guidelines and has no published evidence for treating flashbacks, nightmares, or any PTSD symptoms. The drug's FDA-approved indications are limited to schizophrenia, bipolar I disorder (manic/mixed episodes), and adjunctive treatment of major depressive disorder 2, 3.
What Actually Works for Flashbacks and PTSD Symptoms
First-Line Treatments:
- Image Rehearsal Therapy (IRT) is the only "recommended" treatment for PTSD-associated nightmares 1
- Prazosin is the most evidence-based medication, with Level A recommendation for PTSD-associated nightmares 4
Medications That May Help (Listed in Guidelines):
For PTSD-associated nightmares specifically 1:
- Atypical antipsychotics: olanzapine, risperidone, and aripiprazole (not cariprazine)
- Alpha-2 agonists: clonidine
- Others: cyproheptadine, fluvoxamine, gabapentin, nabilone, phenelzine, topiramate, trazodone, tricyclic antidepressants
Clinical Reasoning for Your Patient
If your patient was on Abilify for "flashbacks," the prescriber was likely targeting:
- PTSD-associated nightmares (which have some evidence with aripiprazole)
- General PTSD symptoms including intrusive thoughts
- Comorbid psychotic symptoms or severe agitation
Switching from aripiprazole to cariprazine for this indication has no supporting evidence and would be inappropriate. While both are dopamine D2/D3 partial agonists, cariprazine has higher D3 receptor affinity and different pharmacologic properties 5, 6, but this does not translate to efficacy for PTSD symptoms.
What to Do Instead
If continuing antipsychotic treatment:
- Stay with aripiprazole if it was providing benefit
- Consider risperidone (2-3 mg/day) or olanzapine (10-20 mg/day), which have better evidence for PTSD-associated nightmares 1
Better evidence-based options:
- Prazosin starting at 1 mg at bedtime, titrating to 3-15 mg based on response (average effective dose ~9-13 mg) 4
- Image Rehearsal Therapy - the only treatment with "recommended" status 1
- Consider SSRI/SNRI for core PTSD symptoms (paroxetine or sertraline are FDA-approved)
Important Caveats:
- Clonazepam is NOT recommended for nightmare disorder despite common use 1
- Venlafaxine is NOT recommended for PTSD-associated nightmares 1
- Monitor for orthostatic hypotension if using prazosin or clonidine 4, 1
- Atypical antipsychotics carry metabolic risks; cariprazine may have a slightly better metabolic profile than some others 7, 5, but this doesn't justify its use without efficacy data for the target symptoms
The bottom line: Vraylar has no role in treating flashbacks or PTSD symptoms. If your patient needs continued pharmacotherapy for these symptoms, evidence supports staying with aripiprazole, switching to prazosin, or adding evidence-based psychotherapy.